TY - JOUR
T1 - Anaphylaxis and mortality induced by treatment of mice with anti-VLA-4 antibody and pertussis toxin
AU - Ji, Niannian
AU - Rao, Nagarjun
AU - Guentzel, Neal M.
AU - Arulanandam, Bernard P.
AU - Forsthuber, Thomas G.
PY - 2011/3/1
Y1 - 2011/3/1
N2 - Ab-mediated blockade of the adhesion molecule VLA-4 has been shown to ameliorate disease in human multiple sclerosis patients and experimental autoimmune encephalomyelitis (EAE) animal models. We wanted to determine whether anti-VLA-4 Ab treatment affected the function and persistence of autoreactive T cells in mice with EAE. Unexpectedly, we observed a high level of mortality in anti-VLA-4 mAb (PS/2)-treated mice with actively induced EAE despite decreased disease severity. Investigation of the underlying mechanism showed that injection of PS/2 mAb in combination with pertussis toxin resulted in anaphylaxis and mortality. Furthermore, the data showed that CD4+ T cells were required for this effect and suggested a role for IL-1β and TNF-α in the underlying pathology. The results reveal a previously not appreciated deleterious effect of anti-VLA-4 Ab treatment in combination with exposure to pertussis toxin.
AB - Ab-mediated blockade of the adhesion molecule VLA-4 has been shown to ameliorate disease in human multiple sclerosis patients and experimental autoimmune encephalomyelitis (EAE) animal models. We wanted to determine whether anti-VLA-4 Ab treatment affected the function and persistence of autoreactive T cells in mice with EAE. Unexpectedly, we observed a high level of mortality in anti-VLA-4 mAb (PS/2)-treated mice with actively induced EAE despite decreased disease severity. Investigation of the underlying mechanism showed that injection of PS/2 mAb in combination with pertussis toxin resulted in anaphylaxis and mortality. Furthermore, the data showed that CD4+ T cells were required for this effect and suggested a role for IL-1β and TNF-α in the underlying pathology. The results reveal a previously not appreciated deleterious effect of anti-VLA-4 Ab treatment in combination with exposure to pertussis toxin.
UR - http://www.scopus.com/inward/record.url?scp=79952750287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952750287&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1000907
DO - 10.4049/jimmunol.1000907
M3 - Article
C2 - 21270409
AN - SCOPUS:79952750287
VL - 186
SP - 2750
EP - 2756
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 5
ER -